Anti-MFSD6L monoclonal antibody

Pre-made anti-MFSD6L monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MFSD6L/MFSD6L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1182-Ab-1/ GM-Tg-hg-IP1182-Ab-2Anti-Human MFSD6L monoclonal antibodyHuman
GM-Tg-rg-IP1182-Ab-1/ GM-Tg-rg-IP1182-Ab-2Anti-Rat MFSD6L monoclonal antibodyRat
GM-Tg-mg-IP1182-Ab-1/ GM-Tg-mg-IP1182-Ab-2Anti-Mouse MFSD6L monoclonal antibodyMouse
GM-Tg-cynog-IP1182-Ab-1/ GM-Tg-cynog-IP1182-Ab-2Anti-Cynomolgus/ Rhesus macaque MFSD6L monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1182-Ab-1/ GM-Tg-felg-IP1182-Ab-2Anti-Feline MFSD6L monoclonal antibodyFeline
GM-Tg-cang-IP1182-Ab-1/ GM-Tg-cang-IP1182-Ab-2Anti-Canine MFSD6L monoclonal antibodyCanine
GM-Tg-bovg-IP1182-Ab-1/ GM-Tg-bovg-IP1182-Ab-2Anti-Bovine MFSD6L monoclonal antibodyBovine
GM-Tg-equg-IP1182-Ab-1/ GM-Tg-equg-IP1182-Ab-2Anti-Equine MFSD6L monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1182-Ab-1/ GM-Tg-hg-IP1182-Ab-2; GM-Tg-rg-IP1182-Ab-1/ GM-Tg-rg-IP1182-Ab-2;
GM-Tg-mg-IP1182-Ab-1/ GM-Tg-mg-IP1182-Ab-2; GM-Tg-cynog-IP1182-Ab-1/ GM-Tg-cynog-IP1182-Ab-2;
GM-Tg-felg-IP1182-Ab-1/ GM-Tg-felg-IP1182-Ab-2; GM-Tg-cang-IP1182-Ab-1/ GM-Tg-cang-IP1182-Ab-2;
GM-Tg-bovg-IP1182-Ab-1/ GM-Tg-bovg-IP1182-Ab-2; GM-Tg-equg-IP1182-Ab-1/ GM-Tg-equg-IP1182-Ab-2
Products NameAnti-MFSD6L monoclonal antibody
Formatmab
Target NameMFSD6L
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MFSD6L monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1182-Ag-1Recombinant multi-species MFS6L/ MFSD6L protein


    Target information

    Target IDGM-IP1182
    Target NameMFSD6L
    Gene ID162387,215723,287414,717575,489496,101081842,614798,100073068
    Gene Symbol and SynonymsMFSD6L,RGD1307767
    Uniprot AccessionQ8IWD5
    Uniprot Entry NameMFS6L_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000185156
    Target ClassificationN/A

    The target: MFSD6L, gene name: MFSD6L, also named as . Predicted to be integral component of membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.